Dingdang Health Announces Further Share Buyback; Total Repurchases Reach 73.72 Million Shares Under 2025 Mandate

Bulletin Express06-11

On 11 June 2026, Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return detailing continued execution of its share repurchase mandate.

The company bought back 64,500 ordinary shares on-market at prices between HK$0.88 and HK$0.90, spending HK$0.06 million. All repurchased shares are earmarked for cancellation.

Since 19 May 2026, Dingdang Health has accumulated 8.89 million shares pending cancellation, acquired at volume-weighted prices ranging from HK$0.83 to HK$0.96 per share. The latest batch represents approximately 0.01% of the company’s 1.25 billion issued shares, while the total pending cancellation equals about 0.71% of the share capital.

Under the repurchase mandate approved on 28 May 2025, the company may buy back up to 131.95 million shares. Including the latest transactions, cumulative repurchases stand at 73.72 million shares, representing 5.59% of the shares outstanding when the mandate was granted.

The issued share count remains unchanged at 1.25 billion shares until the repurchased stock is formally cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or treasury share sales until 11 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142995368?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 20:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142995368","market":"us","top_or_hot":-1,"title":"Dingdang Health Announces Further Share Buyback; Total Repurchases Reach 73.72 Million Shares Under 2025 Mandate","media":"Bulletin Express","content":"<p>On 11 June 2026, Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return detailing continued execution of its share repurchase mandate.</p>\n<p>The company bought back 64,500 ordinary shares on-market at prices between HK$0.88 and HK$0.90, spending HK$0.06 million. All repurchased shares are earmarked for cancellation.</p>\n<p>Since 19 May 2026, Dingdang Health has accumulated 8.89 million shares pending cancellation, acquired at volume-weighted prices ranging from HK$0.83 to HK$0.96 per share. The latest batch represents approximately 0.01% of the company’s 1.25 billion issued shares, while the total pending cancellation equals about 0.71% of the share capital.</p>\n<p>Under the repurchase mandate approved on 28 May 2025, the company may buy back up to 131.95 million shares. Including the latest transactions, cumulative repurchases stand at 73.72 million shares, representing 5.59% of the shares outstanding when the mandate was granted.</p>\n<p>The issued share count remains unchanged at 1.25 billion shares until the repurchased stock is formally cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or treasury share sales until 11 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Announces Further Share Buyback; Total Repurchases Reach 73.72 Million Shares Under 2025 Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Announces Further Share Buyback; Total Repurchases Reach 73.72 Million Shares Under 2025 Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 20:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 11 June 2026, Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return detailing continued execution of its share repurchase mandate.</p>\n<p>The company bought back 64,500 ordinary shares on-market at prices between HK$0.88 and HK$0.90, spending HK$0.06 million. All repurchased shares are earmarked for cancellation.</p>\n<p>Since 19 May 2026, Dingdang Health has accumulated 8.89 million shares pending cancellation, acquired at volume-weighted prices ranging from HK$0.83 to HK$0.96 per share. The latest batch represents approximately 0.01% of the company’s 1.25 billion issued shares, while the total pending cancellation equals about 0.71% of the share capital.</p>\n<p>Under the repurchase mandate approved on 28 May 2025, the company may buy back up to 131.95 million shares. Including the latest transactions, cumulative repurchases stand at 73.72 million shares, representing 5.59% of the shares outstanding when the mandate was granted.</p>\n<p>The issued share count remains unchanged at 1.25 billion shares until the repurchased stock is formally cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or treasury share sales until 11 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1142995368","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142995368","pubTimestamp":1781180464,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 11 June 2026, Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return detailing continued execution of its share repurchase mandate. The company bought back...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康宣布进一步回购股份；根据2025年授权，回购总数达到7372万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"On 11 June 2026, Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return detailing continued execution of its share repurchase mandate.\nThe company bought back 64,500 ordinary shares on-market at prices between HK$0.88 and HK$0.90, spending HK$0.06 million. All repurchased shares are earmarked for cancellation.\nSince 19 May 2026, Dingdang Health has accumulated 8.89 million shares pending cancellation, acquired at volume-weighted prices ranging from HK$0.83 to HK$0.96 per share. The latest batch represents approximately 0.01% of the company’s 1.25 billion issued shares, while the total pending cancellation equals about 0.71% of the share capital.\nUnder the repurchase mandate approved on 28 May 2025, the company may buy back up to 131.95 million shares. Including the latest transactions, cumulative repurchases stand at 73.72 million shares, representing 5.59% of the shares outstanding when the mandate was granted.\nThe issued share count remains unchanged at 1.25 billion shares until the repurchased stock is formally cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or treasury share sales until 11 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142995368","isCrawlerRequest":true}